focus -WSS

focus

author：Wikipedia 2025-10-02 09:45:19 - browse：817

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Listen: PBM conflicts, RSV vaccines, & the future of flu season

hotspot

WSS

Can food be medicine? And other questions about a new push

FDA seeks to regulate lab

FDA advisers vote against ALS treatment from BrainStorm

Mindstrong's demise and the future of mental health care

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

4th of July breaks record for highest global temperature ever measured

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

How to save PrEP access — and even expand it

Biogen shutters digital health group, ends Apple study, in cost cutting move

Duchenne breakthrough therapy leaves behind pioneering families

7 people shot in DC, police say

What does generative AI mean for health care? We asked experts

RaDonda Vaught case: a double standard for nurses, physicians

Walensky prepares to leave CDC — and Congress — behind

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Duchenne breakthrough therapy leaves behind pioneering families

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

knowledge

Medicaid, Medicare dual

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Can food be medicine? And other questions about a new push

Listen: PBM conflicts, RSV vaccines, & the future of flu season

After a drawn out lobbying fight, ARPA

Did the public have the right to know Arthur Ashe had AIDS?

hotspot

Wikipedia

focus

focus